These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 1359204

  • 1. Biological markers and minimal residual disease in hairy cell leukemia.
    Lauria F, Raspadori D, Benfenati D, Rondelli D, Pallotti A, Tura S.
    Leukemia; 1992 Nov; 6 Suppl 4():149-51. PubMed ID: 1359204
    [Abstract] [Full Text] [Related]

  • 2. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.
    Chrobák L, Podzimek K, Plísková L, Kerekes Z, Zák P, Voglová J, Spacek J, Palicka V.
    Neoplasma; 1996 Nov; 43(5):321-5. PubMed ID: 8996552
    [Abstract] [Full Text] [Related]

  • 3. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P, Chrobák L, Dĕdic K, Podzimek K.
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [Abstract] [Full Text] [Related]

  • 4. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995 Oct; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 Oct; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 6. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
    Arun B, Curti BD, Longo DL, Stevens D, Alvord WG, Gause BL, Watson T, Kopp WC, Janik JE.
    Cancer J Sci Am; 2000 Oct; 6(1):21-4. PubMed ID: 10696734
    [Abstract] [Full Text] [Related]

  • 7. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
    Miyamoto T, Akashi K, Hayashi S, Gondo H, Murakawa M, Tanimoto K, Harada M, Niho Y.
    Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U, Gawaz M, Grunewald R, Hill W, Lorenz B, Stôtzer O.
    Anticancer Res; 1993 Feb; 13(5C):1809-14. PubMed ID: 7903521
    [Abstract] [Full Text] [Related]

  • 9. Long-term results in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Chrobák L, Zák P, Podzimek K, Plísková L, Foglová J, Maisnar V, Dulícek P, Dĕdic K.
    Acta Medica (Hradec Kralove); 1997 Feb; 40(2):41-5. PubMed ID: 9389210
    [Abstract] [Full Text] [Related]

  • 10. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia.
    Cimino G, Annino L, Giona F, Sgadari C, Di Gregorio AO, Cava MC, Cimino G, Mandelli F.
    Leukemia; 1991 Jul; 5(7):602-5. PubMed ID: 2072745
    [Abstract] [Full Text] [Related]

  • 11. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
    Cimino G, Amadori S, Cava MC, De Sanctis V, Petti MC, Di Gregorio AO, Sgadari C, Vegna L, Cimino G, Mandelli F.
    Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.
    Lauria F, Foà R, Raspadori D, Pileri S, Tassinari A, Buzzi M, Zaccaria A, Zinzani PL, Tura S.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():176-8. PubMed ID: 2785426
    [Abstract] [Full Text] [Related]

  • 13. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I, Zdziarska B, Krygier-Stojałowska A.
    Acta Haematol Pol; 1996 Jan; 27(1):49-55. PubMed ID: 8629443
    [Abstract] [Full Text] [Related]

  • 14. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Lauria F, Benfenati D, Raspadori D, Rondelli D, Zinzani PL, Tura S.
    Leuk Lymphoma; 1993 Nov; 11(5-6):399-404. PubMed ID: 7907247
    [Abstract] [Full Text] [Related]

  • 15. Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
    Barak V, Nisman B, Polliack A, Vannier E, Dinarello CA.
    Eur Cytokine Netw; 1998 Mar; 9(1):33-9. PubMed ID: 9613675
    [Abstract] [Full Text] [Related]

  • 16. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
    Chrobák L, Podzimek K, Zak P, Plísková L, Voglová J.
    Acta Haematol Pol; 1995 Mar; 26(2 Suppl 1):56-62. PubMed ID: 7653236
    [Abstract] [Full Text] [Related]

  • 17. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V.
    Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
    [Abstract] [Full Text] [Related]

  • 18. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
    Kandefer-Szerszeń M, Legieć W, Dmoszyńska A, Rzeski W.
    Arch Immunol Ther Exp (Warsz); 1997 Sep; 45(5-6):443-8. PubMed ID: 9437500
    [Abstract] [Full Text] [Related]

  • 19. The tumor necrosis factor family and and correlation with disease activity and response to treatment in hairy cell leukemia.
    Barak V, Nisman B, Polliack A.
    Eur J Haematol; 1999 Feb; 62(2):71-5. PubMed ID: 10052708
    [Abstract] [Full Text] [Related]

  • 20. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X, Blade J, Guillermo AL, Molina R, Rozman C, Ballesta AM.
    Cancer Detect Prev; 1996 Feb; 20(1):52-6. PubMed ID: 8907203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.